KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Times Interest Earned (2016 - 2023)

Supernus Pharmaceuticals (SUPN) has disclosed Times Interest Earned for 13 consecutive years, with -$19.33 as the latest value for Q2 2023.

  • On a quarterly basis, Times Interest Earned fell 408.31% to -$19.33 in Q2 2023 year-over-year; TTM through Mar 2024 was -$14.94, a 300.91% decrease, with the full-year FY2023 number at -$2.18, down 133.44% from a year prior.
  • Times Interest Earned was -$19.33 for Q2 2023 at Supernus Pharmaceuticals, down from $3.44 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $21.54 in Q4 2022 to a low of -$19.33 in Q2 2023.
  • A 5-year average of $4.58 and a median of $5.87 in 2021 define the central range for Times Interest Earned.
  • Peak YoY movement for Times Interest Earned: surged 1996.02% in 2022, then tumbled 408.31% in 2023.
  • Supernus Pharmaceuticals' Times Interest Earned stood at $7.07 in 2019, then fell by 0.17% to $7.05 in 2020, then crashed by 85.43% to $1.03 in 2021, then soared by 1996.02% to $21.54 in 2022, then tumbled by 189.73% to -$19.33 in 2023.
  • Per Business Quant, the three most recent readings for SUPN's Times Interest Earned are -$19.33 (Q2 2023), $3.44 (Q1 2023), and $21.54 (Q4 2022).